206 related articles for article (PubMed ID: 32387665)
1. Field cancerization: Definition, epidemiology, risk factors, and outcomes.
Willenbrink TJ; Ruiz ES; Cornejo CM; Schmults CD; Arron ST; Jambusaria-Pahlajani A
J Am Acad Dermatol; 2020 Sep; 83(3):709-717. PubMed ID: 32387665
[TBL] [Abstract][Full Text] [Related]
2. Field cancerization: Treatment.
Cornejo CM; Jambusaria-Pahlajani A; Willenbrink TJ; Schmults CD; Arron ST; Ruiz ES
J Am Acad Dermatol; 2020 Sep; 83(3):719-730. PubMed ID: 32387663
[TBL] [Abstract][Full Text] [Related]
3. Actinic keratosis and squamous cell carcinoma: clinical and pathological features.
Filosa A; Filosa G
G Ital Dermatol Venereol; 2015 Aug; 150(4):379-84. PubMed ID: 26099352
[TBL] [Abstract][Full Text] [Related]
4. [Beyond actinic keratoses: Field cancerization of the skin].
Reygagne P; Rostain G
Ann Dermatol Venereol; 2018 Oct; 145(10):587-592. PubMed ID: 30243819
[TBL] [Abstract][Full Text] [Related]
5. Contribution to characterization of skin field cancerization activity: morphometric, chromatin texture, proliferation, and apoptosis aspects.
Miola AC; Castilho MA; Schmitt JV; Marques MEA; Miot HA
An Bras Dermatol; 2019; 94(6):698-703. PubMed ID: 31789247
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous Squamous Cell Carcinomas of the Lower Extremities Show Distinct Clinical and Pathologic Features.
Solus JF; Murphy GF; Kraft S
Int J Surg Pathol; 2016 Feb; 24(1):29-36. PubMed ID: 26261102
[TBL] [Abstract][Full Text] [Related]
7. Actinic keratoses, actinic field change and associations with squamous cell carcinoma in renal transplant recipients in Manchester, UK.
Wallingford SC; Russell SA; Vail A; Proby CM; Lear JT; Green AC
Acta Derm Venereol; 2015 Sep; 95(7):830-4. PubMed ID: 25784002
[TBL] [Abstract][Full Text] [Related]
8. Actinic keratosis as a marker of field cancerization in excision specimens of cutaneous malignancies.
Lanoue J; Chen C; Goldenberg G
Cutis; 2016 Jun; 97(6):415-20. PubMed ID: 27416085
[TBL] [Abstract][Full Text] [Related]
9. Swiss clinical practice guidelines on field cancerization of the skin.
Hofbauer G; Anliker M; Boehncke WH; Brand C; Braun R; Gaide O; Hafner J; Hunger R; Itin P; Kaeuper G; Lautenschlager S; Mainetti C; Streit M
Swiss Med Wkly; 2014; 144():w14026. PubMed ID: 25539459
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial.
Miola AC; Ferreira ER; Lima TRR; Schmitt JV; Abbade LPF; Miot HA
Br J Dermatol; 2018 Nov; 179(5):1081-1087. PubMed ID: 29862491
[TBL] [Abstract][Full Text] [Related]
11. Actinic keratoses: review of clinical, dermoscopic, and therapeutic aspects.
Reinehr CPH; Bakos RM
An Bras Dermatol; 2019; 94(6):637-657. PubMed ID: 31789244
[TBL] [Abstract][Full Text] [Related]
12. [Not Available].
Velter C
Ann Dermatol Venereol; 2019 May; 146 Suppl 2():IIS3-IIS9. PubMed ID: 31133227
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer.
Puviani M; Barcella A; Milani M
G Ital Dermatol Venereol; 2013 Dec; 148(6):693-8. PubMed ID: 24442053
[TBL] [Abstract][Full Text] [Related]
14. Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation.
Berman B; Cockerell CJ
J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S10-9. PubMed ID: 23228301
[TBL] [Abstract][Full Text] [Related]
15. Systematic review of randomized controlled trials of topicals for actinic keratosis field therapy.
Patel P; Wang J; Bitterman D; Mineroff J; Austin E; Jagdeo J
Arch Dermatol Res; 2024 Mar; 316(4):108. PubMed ID: 38498070
[TBL] [Abstract][Full Text] [Related]
16. Actinic keratosis: precancer, squamous cell carcinoma, or marker of field cancerization?
Deltondo JA; Helm KF
G Ital Dermatol Venereol; 2009 Aug; 144(4):441-4. PubMed ID: 19755947
[TBL] [Abstract][Full Text] [Related]
17. Actinic Keratoses: Reconciling the Biology of Field Cancerization with Treatment Paradigms.
Gilchrest BA
J Invest Dermatol; 2021 Apr; 141(4):727-731. PubMed ID: 32956650
[TBL] [Abstract][Full Text] [Related]
18. [Non-melanoma skin cancer : Pathogenesis, prevalence and prevention].
Zink A
Hautarzt; 2017 Nov; 68(11):919-928. PubMed ID: 29018888
[TBL] [Abstract][Full Text] [Related]
19. European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization on behalf of European Association of Dermato-Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes).
Kandolf L; Peris K; Malvehy J; Mosterd K; Heppt MV; Fargnoli MC; Berking C; Arenberger P; Bylaite-Bučinskiene M; Del Marmol V; Dirschka T; Dreno B; Forsea AM; Harwood CA; Hauschild A; Heerfordt IM; Kauffman R; Kelleners-Smeets N; Lallas A; Lebbe C; Leiter U; Longo C; Mijušković Ž; Pellacani G; Puig S; Saiag P; Šitum M; Stockfleth E; Salavastru C; Stratigos A; Zalaudek I; Garbe C;
J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):1024-1047. PubMed ID: 38451047
[TBL] [Abstract][Full Text] [Related]
20. Actinic keratosis among seafarers.
Oldenburg M; Kuechmeister B; Ohnemus U; Baur X; Moll I
Arch Dermatol Res; 2013 Nov; 305(9):787-96. PubMed ID: 23818098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
